Speech by Chancellor Scholz on the occasion of his visit to Bayer AG on May 13, 2022, in Leverkusen

Germany Olaf Scholz · Member of the Bundestag

13 May 2022 · Visit to Bayer AG · Bayer AG, Leverkusen, Germany

Context
Scholz addressed Bayer AG executives, employees, and local officials during a visit to the Leverkusen pharmaceutical production site on May 13, 2022.
Main themes
Russia-Ukraine war and geopolitical turning point, energy independence and fossil fuel reduction, industrial and ecological transformation, pharmaceutical production resilience, Bayer AG investment in Leverkusen, supply chain diversification, renewable energy expansion, worker co-determination, Germany's economic competitiveness, planning and approval process reform, digitalization in manufacturing
Duration
~8 min
27th percentile
Words
916
27th percentile
Sentences
56
37th percentile
Readability
42
42nd percentile
Grade
11.4
37th percentile
Syntax
2.77
19th percentile
Vocabulary
2.20
49th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 46%46%
  • Ceremonial 18%18%
  • Environmental 11%11%
  • Institutional 11%11%
  • Geopolitical 9%9%
  • Social 5%5%
  • Technological 0%0%
  • Not in focus 0%

56 sentences in 20 paragraphs

Dear Mr. Baumann!

Dear Ms. Hausfeld!

Dear Mayor Richrath!

Dear Karl Lauterbach!

Ladies and gentlemen!

In inorganic chemistry, with which Bayer AG has grown, one is accustomed to violent reactions under the highest energy input. This also applies to international politics, at least since February 24. That is the day Russia attacked Ukraine.

You all know, I spoke in the German Bundestag about a turning point in history. This war marks a turning point because it threatens the entire international peace order. This war also marks a turning point because it forces us to tackle global challenges that already existed before with even greater determination.

To stick with chemical terminology: The new situation that has now arisen must be the catalyst that drives our industrial and ecological transformation even more vigorously – now more than ever.

This applies, for example, to our dependence on gas, oil, and coal from Russia. That is why the federal government is working even harder to reduce our dependence on fossil energy and to transition our energy supply. We have secured floating liquefied natural gas terminals and opened new sources of supply. And we are building the necessary infrastructure, and significantly faster than such large projects have been realized in Germany so far. Because we know what is at stake: It is about the economic future of our country.

And to be clear: We want this country to still be a highly innovative and competitive country in 10, 20, and 50 years – an industrial nation. This includes making faster progress in expanding renewable energies. Bayer AG aims to reduce its emissions by 42 percent by 2030 and to be climate-neutral by 2050. How absolutely correct this course is, the Russian war against Ukraine shows us once again in a completely new light.

We must also thoroughly reassess our supply of strategically important imports. We learned this during the past years of the pandemic with its growing supply chain problems, and they showed us something: We need more diversification and greater resilience. This is especially true for high-quality and innovative pharmaceuticals.

In this context, it is the right step at the right time that one of the world's most modern production facilities for pharmaceuticals is now being established here at the Bayer site in Leverkusen. This new facility will set standards in terms of quality, delivery reliability, and energy efficiency. I was able to learn and understand this during our discussions. Furthermore, I heard that this is the result of a very active social partnership that prepared the foundations for this decision very early on. The facility will utilize all the opportunities of digitalization as a learning factory. I learned that as well.

I am particularly impressed that the employees are directly involved in the planning process of the facility. Because I am deeply convinced that this kind of employee participation and co-determination of informed workers is one of the great strengths of our global German economic model.

Ladies and gentlemen, with this investment, you are demonstrating great confidence in the Leverkusen site and in the region as a center of the chemical and pharmaceutical industry. This is also good for our entire country. Because investment and innovation projects like this not only create secure jobs locally. They also radiate economic performance and future viability. They attract further investments, development capacities, and skilled workers. Projects like this are absolutely crucial for Germany to remain among the global leaders economically and technologically in the 21st century.

I am aware that the chemical and pharmaceutical industry is particularly challenged in the context of ecological transformation. On the one hand, energy-intensive production processes often take place there. On the other hand, many of its products form the basis for the success of ecological and digital transformation. Or to put it even more clearly: Only if we succeed in the transformation of the chemical and pharmaceutical industry will we also succeed in the transformation and further development of our entire economy.

That is why the federal government will do everything today and in the future to enable this development process. We are reducing bureaucracy to specifically strengthen the production of pharmaceuticals in Germany and the EU. We have also discussed this in depth. There is still more to be done.

We want to halve the duration of planning and approval processes so that public and private investments arrive faster, more efficiently, and more purposefully. We are currently setting an example – and I hope we learn from this for the future. With the so-called Easter package, the federal government has already laid the foundation for an accelerated expansion of renewable energies. The "Summer Package" will set the impulses for providing land for the necessary facilities and for planning and approval processes.

And finally, we will not leave companies alone with rising energy costs. Through loans and grants, we are particularly supporting energy-intensive sectors so that they can make the necessary investments on the path to climate neutrality while maintaining their international competitiveness.

Ladies and gentlemen, not only today, but on a day like this especially, I am sure: Together we will manage the transformation of the chemical and pharmaceutical industry and thus the ecological and digital transformation of the German economy as a whole. This facility stands for that. That is why today is a good day: for Bayer AG with its employees, for the Leverkusen site and the region, for the state of North Rhine-Westphalia, and also for Germany as a whole.

Thank you.